Skip to main content
Equibles

INSECTICID · Insecticides (India) Limited · Financials

Use INSECTICID with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research INSECTICID.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
541.00 INR -3.50 (-0.64%) At close · Nov 13
Rebalance outlook locked
Volume · Nov 13 95 Avg daily vol (3M) 953

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
21.4B +7%
FY2026 Revenue FY2020–FY2026
Net Income
1.39B
FY2026 Net Income FY2020–FY2026
Operating Cash Flow
1B +7.3%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
INR 21.09B 21.4B 20B 19.66B 18.01B 15.04B 14.2B 13.63B
INR 384.54M 354.96M 291.53M 292.5M 261.02M 263.49M 246.72M 240.72M
INR 202.77M 168.79M 68.65M 108.88M 134.51M 66.34M 66.51M 238.9M
INR 423.1M 472.68M 507.51M 298.26M 206.18M 339.44M 256.01M 244.21M
INR 1.1B 1.39B 0 0 632.11M 1.07B 0 869.13M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 354.18M in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.